phase readout
saveNCT03284710: Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
COMPLETEDupdated 6m ago
community read0 votes
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: HIV Infections
view source ↗
comments(0)
5-min edit window · permanent after that